Conference Coverage

Rivaroxaban bonus: Early unmasking of occult GI cancers

Publish date: September 22, 2018

 

REPORTING FROM THE ESC CONGRESS 2018

Pages

Recommended Reading

DOACs found safer than warfarin in the real world
MDedge Cardiology
How to identify DVT faster in pediatric osteomyelitis
MDedge Cardiology
No benefit of direct stenting in PCI
MDedge Cardiology
Guideline: PFO closure best bet for recurrent stroke prevention
MDedge Cardiology
Blood pressure control prevents cognitive impairment
MDedge Cardiology
VTE risk unchanged by rivaroxaban after discharge
MDedge Cardiology
Rivaroxaban superior to aspirin for extended VTE treatment
MDedge Cardiology
New stroke intervention guidelines stress volume
MDedge Cardiology
Think DEB, not BMS, with high bleeding risk
MDedge Cardiology
Expert panel updates guidelines on antithrombotic therapy for AF
MDedge Cardiology